Search
for
Sort by
Research 121–150 of 268
- Effects of 5-alpha reductase inhibitors
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Debatable Topics in PCOS Patients
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Understanding Polycystic Ovary Syndrome
- Antioxidant and 5α-Reductase Inhibitory Activity of Momordica charantia Extract, and Development and Characterization of Microemulsion
- Quercetin Nanocrystal Gel: A Novel Topical Therapeutic Strategy for Androgenetic Alopecia
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in treatment of male androgenic alopecia
- Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
- Effects of the use of finasteride on prostate volume and serum PSA in young patients
- Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men
- Steroid Sulfatase in the Human Hair Follicle Concentrates in the Dermal Papilla
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
- Bioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia
- O que sabemos sobre os inibidores da 5 alfa redutase?
- The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
- Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males
- Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments
- Evaluation of the safety and efficacy of concentrated growth factors for hair growth promotion in androgenetic alopecia patients: A retrospective single‐centre, single‐arm study
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption
- An Uncontrolled Case Series Using a Botanically Derived, β-Cyclodextrin Inclusion Complex in Two Androgenetic Alopecia-Affected Male Subjects
- Phytochemicals and novel delivery systems in alopecia management: An integrative review
- NANOCARRIER-BASED APPROACHES FOR ENHANCED MANAGEMENT OF ANDROGENETIC ALOPECIA: ADVANCEMENTS AND FUTURE PROSPECTS